arrow
Return

Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C

delete2018-04-30
delete12
delete
OA
AI
C
Chaohua Peng
G
Gaochun Zhu
X
Xiangqian Liu
H
He Li *
DOI:10.1007/s12264-018-0230-xdelete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Huntington's disease (HD) is a neurodegenerative disease caused by a polyglutamine expansion in the huntingtin (Htt) protein. Mutant Htt causes synaptic transmission dysfunctions by interfering in the expression of synaptic proteins, leading to early HD symptoms. Synaptic vesicle proteins 2 (SV2s), a family of synaptic vesicle proteins including 3 members, SV2A, SV2B, and SV2C, plays important roles in synaptic physiology. Here, we investigated whether the expression of SV2s is affected by mutant Htt in the brains of HD transgenic (TG) mice and Neuro2a mouse neuroblastoma cells (N2a cells) expressing mutant Htt. Western blot analysis showed that the protein levels of SV2A and SV2B were not significantly changed in the brains of HD TG mice expressing mutant Htt with 82 glutamine repeats. However, in the TG mouse brain there was a dramatic decrease in the protein level of SV2C, which has a restricted distribution pattern in regions particularly vulnerable in HD. Immunostaining revealed that the immunoreactivity of SV2C was progressively weakened in the basal ganglia and hippocampus of TG mice. RT-PCR demonstrated that the mRNA level of SV2C progressively declined in the TG mouse brain without detectable changes in the mRNA levels of SV2A and SV2B, indicating that mutant Htt selectively inhibits the transcriptional expression of SV2C. Furthermore, we found that only SV2C expression was progressively inhibited in N2a cells expressing a mutant Htt containing 120 glutamine repeats. These findings suggest that the synaptic dysfunction in HD results from the mutant Htt-mediated inhibition of SV2C transcriptional expression. These data also imply that the restricted distribution and decreased expression of SV2C contribute to the brain region-selective pathology of HD.
Keywords:
Synaptic vesicle protein 2C
Huntington's disease
Basal ganglia
Hippocampus
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Neuroscience Bulletin cover
Neuroscience Bulletin
IF:
5.8
Papers:
2.2K
Citations:
5.4K

Organization

No organization information available
Cited Papers

Cited Papers

Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF
err2016-11-27
err27
errOAAI
errPuigdellivol, Mar; Saavedra, Ana; Perez-Navarro, Esther
errShare
errSave
Huntington's disease
err2010-06-30
err172
PREAI
errNovak, Marianne J. U.; Tabrizi, Sarah J.
errShare
errSave
Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease
err2016-03-01
err28
PREAI
errBuren, Caodu; Parsons, Matthew P.; Smith-Dijak, Amy; Raymond, Lynn A.
errShare
errSave
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease
err2008-06-16
err150
errOAAI
errWang, Chuan-En; Tydlacka, Suzanne; Orr, Adam L.; Yang, Shang-Hsun; Graham, Rona K.; Hayden, Michael R.; Li, Shihua; Chan, Anthony W. S.; Li, Xiao-Jiang
errShare
errSave
Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts
err2006-04-01
err0
PREAI
errPaola Fadda; Lianne Robinson; Walter Fratta; Roger G. Pertwee; Gernot Riedel
errShare
errSave
Progress with inventories
err1993-05-01
err0
errOAAI
errFrank A. Bisby
errShare
errSave
researcher View more